Testing effectiveness (Phase 2)Ended earlyNCT00193024
What this trial is testing
Epirubicin and Docetaxel in the Treatment of Patients With Metastatic Breast Cancer
Who this might be right for
Breast Cancer
SCRI Development Innovations, LLC 90
Showing 20 of 0 results